| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.24 ▲ +4.43% | Yesterday | $2.15 ▼ -0.23% | Tomorrow's NervGen Pharma Corp. Common stock (NGEN) setup is anchored to $2.15 and targets $2.24 (+4.43%). The near-term read is upside; watch $2.25 / $2.04 because daily realized volatility is about 13.82%. |
Tomorrow's NervGen Pharma Corp. Common stock (NGEN) setup is anchored to $2.15 and targets $2.24 (+4.43%). The near-term read is upside; watch $2.25 / $2.04 because daily realized volatility is about 13.82%. | ||||
| Week | $2.38 ▲ +10.96% | Last Week | $2.15 ▼ -0.23% | The 7-day NervGen Pharma Corp. Common stock model moves from $2.15 to $2.38 (+10.96%). It gives upside momentum context for this stock, so breaks around $2.25 / $2.04 matter more than a single tick. |
The 7-day NervGen Pharma Corp. Common stock model moves from $2.15 to $2.38 (+10.96%). It gives upside momentum context for this stock, so breaks around $2.25 / $2.04 matter more than a single tick. | ||||
| Month | $2.57 ▲ +19.81% | Last Month | $2.15 ▼ -0.23% | The 1-month NervGen Pharma Corp. Common stock target is $2.57 (+19.81%), compared with the live reference near $2.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month NervGen Pharma Corp. Common stock target is $2.57 (+19.81%), compared with the live reference near $2.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.83 ▲ +31.93% | Last Year | $2.15 ▼ -0.23% | The 1-year NervGen Pharma Corp. Common stock scenario points to $2.83 (+31.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year NervGen Pharma Corp. Common stock scenario points to $2.83 (+31.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $3.40 ▲ +58.51% | 5 Years Ago | $2.15 ▼ -0.23% | The 5-year NervGen Pharma Corp. Common stock view is $3.40 (+58.51%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year NervGen Pharma Corp. Common stock view is $3.40 (+58.51%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 97.3 | Bullish |
| MACD | 0.10 | Bullish |
| SMA 50 | $2.27 | Mid |
| SMA 200 | $2.23 | Mid |
| EMA 20 | $2.28 | Mid |
| Opening Price | $2.15 | Start Date | 2021-05-26 |
| Day Range | $1.95 – $2.34 | Market Cap | $282.60M |
| Monthly Range | $1.79 – $3.00 | 24h Volume | n/a |
| 90D Range | $1.67 – $3.14 | Circulating | n/a |
| 52W Range | $1.52 – $3.65 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.